Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® Gastrointestinal Infections specialty page provides gastrointestinal infection-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

GASTROINTESTINAL INFECTIONS VIDEOS - Page 1

<i>C. difficile</i> Rates in the United Kingdom
Dr. Richard Vickers, discusses C. difficile rates in the United Kingdom.
Fecal Transplantation in <i>Clostridium difficile</i>
Lawrence J. Brandt, MD; Erik Dubberke, MD; Daniel E. Freedberg, MD, MS; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, consider variables surrounding the use of fecal transplantation for the management of Clostridium difficile in select groups of patients.
<i>Clostridium difficile</i>: The Role of Bezlotoxumab
Lawrence J. Brandt, MD; Erik Dubberke, MD; Daniel E. Freedberg, MD, MS; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, introduce bezlotoxumab, an additional treatment option that is in the pipeline for Clostridium difficile; explore how it works; and suggest which types of patients may be most appropriate to receive this treatment.
What Are the Next Steps for Ridinilazole?
Dr. Richard Vickers, discusses what the next steps are for Summit Therapeutic’s ridinilazole.
Community Sources of <i>Clostridium difficile</i>
Following a general discussion on risk factors for Clostridium difficile, Lawrence J. Brandt, MD; Erik Dubberke, MD; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, distinguish which factors increase the likelihood for community onset.
Governmental Intervention Needed to Ensure Hospital Mattresses Get Cleaned Appropriately
Edmond Hooker, MD, DrPH, stresses that the FDA and the CDC need to intervene to ensure that hospital mattresses get cleaned appropriately.
Understanding What Motivates Health Care Works Crucial to Reducing <i>C. diff</i> Rates
Barley Chironda, RPN, CIC, stresses that understanding what motivates health care workers’ actions is crucial for reducing C. diff rates in hospitals.
Costs of Care Considerations in <i>Clostridium difficile</i>
In this segment, Erik Dubberke, MD; Daniel E. Freedberg, MD, MS; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, remark on the financial burden of Clostridium difficile, highlighting recurrent disease as a contributing factor and, consequently, considering the cost-effectiveness of treating appropriate candidates with fidaxomicin.
FEATURED
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.